SCHEMBL12147263

SCHEMBL12147263

C=C(CC(=O)NO)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
FOLH1 Q04609 3/20 0.42
KDM4E B2RXH2 1/20 0.42
KDM6B O15054 1/20 0.42
KDM5C P41229 1/20 0.42
EGLN1 Q9GZT9 1/20 0.42
PHF8 Q9UPP1 1/20 0.42
KDM2A Q9Y2K7 1/20 0.42
ECE1 P42892 1/20 0.39
HDAC8 Q9BY41 4/20 0.38
HDAC6 Q9UBN7 4/20 0.38
HDAC2 Q92769 3/20 0.38
HDAC3 O15379 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC5 Q9UQL6 1/20 0.38
TET2 Q6N021 5/20 0.37
TET3 O43151 1/20 0.37
TET1 Q8NFU7 1/20 0.37
GRIK1 P39086 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1809603 0.78 ALOX15 (0.57) ALOX15HSD17B10TET2TET3TET1
SCHEMBL3895585 0.76 ALOX15 (0.44) ALOX15HSD17B10KDM4EKDM5CEGLN1
SCHEMBL2605603 0.76 ALOX15 (0.44) ALOX15HSD17B10ECE1HDAC8HDAC6
SCHEMBL11345101 0.74 ALOX15 (0.43) ALOX15HSD17B10TET2TET3TET1
SCHEMBL822245 0.73
Itaconate SCHEMBL29886131 0.73
Itaconate SCHEMBL21523 0.73
Itaconate SCHEMBL286967 0.73 ALOX15 (0.75) ALOX15HSD17B10KDM4EEGLN1TET2
SCHEMBL5177523 0.72 MCL1 (0.41) ALOX15HSD17B10KDM4ETET2TET3
Malonodihydroxamic Acid SCHEMBL3246123 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2389342-B1 SURFACE-MODIFIED ZIRCONIA NANOPARTICLES 3M INNOVATIVE PROPERTIES CO (US) 2020-11-04 EP disclosed
US-8829079-B2 Surface-modified zirconia nanoparticles 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-09-09 US disclosed
US-8829079-B2 Surface-modified zirconia nanoparticles 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-09-09 US disclosed
US-20110288215-A1 SURFACE-MODIFIED ZIRCONIA NANOPARTICLES 3M INNOVATIVE PROPERTIES COMPANY 2011-11-24 US disclosed
US-20110288215-A1 SURFACE-MODIFIED ZIRCONIA NANOPARTICLES 3M INNOVATIVE PROPERTIES COMPANY 2011-11-24 US disclosed
WO-2010085427-A1 SURFACE-MODIFIED ZIRCONIA NANOPARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288215-A1 SURFACE-MODIFIED ZIRCONIA NANOPARTICLES ZKSCAN2, CD63, HDAC9 ALOX15 3256/4885HSD17B10 3455/4885FOLH1 1908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.